New research suggests enhancing the brain’s own immune cells could help clear plaques associated with Alzheimer’s disease.

The amyloid-β precursor protein (APP) helps to form links between the brain’s neurons. It has been highly studied because its ...

If amyloid plaques can be cleared from the brain before they trigger the formation of tau pathology — the key driver of cognitive decline in Alzheimer's patients — the cascade is halted before ...

For decades, scientists have focused on amyloid plaques—abnormal clumps of misfolded proteins that accumulate between neurons ...

Alzheimer’s disease is the most common cause of dementia and the sixth leading cause of death in the United States. It ...

Researchers at Northwestern University have made a breakthrough in identifying a way for Alzheimer's disease to be treated ...

The brain of a US woman with Down syndrome showed the classic signs of Alzheimer’s disease upon her death, yet she remained ...

Scientists have long been racking their brains for ways to treat Alzheimer’s disease, the most common type of dementia.

Northwestern researchers made progress on new biochemical possibilities this week, in both the human brain and everyday ...

A new study suggests a promising alternative to previous attempts to remove the sticky, toxic amyloid beta plaques from brains with Alzheimer's Disease: enhancing the brain's own immune cells to clear ...

For more than three decades, scientists have been racing to stop Alzheimer's disease by removing amyloid beta plaques—sticky clumps of toxic protein that accumulate in the brain. The findings ...